Sandoz Global

13/04/2026

🎉 20 years ago, the world’s first biosimilar, developed by Sandoz, was approved in Europe, ushering in a new era in medicine. That moment helped launch an entirely new industry.

Today, around 120 biosimilars are approved worldwide, expanding access to cutting edge biologic medicines and supporting stronger, more sustainable healthcare systems.

💡 And the momentum is only growing.
With USD 320 billion in biologic patents set to expire over the next decade, we’re entering a golden decade for patient access to affordable medicines, a major opportunity to improve access, affordability and sustainability across global healthcare.
As the pioneer from the start, Sandoz continues to help shape what comes next.

▶️ Watch the video to learn what biosimilars are and how they help treat diseases such as cancer.

07/04/2026

Antibiotics are the backbone of modern medicine — but rising economic pressures and increasing antimicrobial resistance are putting their future at risk.

AMR doesn’t just impact hospitals and healthcare systems. Behind every “resistant infection” is a real person facing delayed or ineffective treatment.

This World Health Day, we’re raising awareness about why protecting antibiotics is essential for global health.

At Sandoz, we supply more than 50 antibiotics worldwide - including many on the WHO Essential Medicines List - and we work across sectors to help preserve their effectiveness for future generations.

📺 Watch the full film: https://www.sandoz.com/business/generics

👉 This film was produced for Sandoz by BBC StoryWorks Commercial Productions as part of the Healthier Together series presented by the WHO Foundation.

02/04/2026

For too long, antibiotics have been purchased based almost entirely on price. And while affordability matters, this race to the lowest offer has created deep structural challenges.

As Simon Goeller points out, constant margin erosion weakens production capacity, reduces diversification and ultimately puts long‑term supply resilience at risk.

It raises an important question:
👉 Should a full treatment cycle for an essential antibiotic really cost less than a pack of chewing gum?

When prices drop that low, the system is essentially saying that resilience, sustainability and security of supply don’t matter — when in reality, they matter more than ever.

If Europe wants true sovereignty in essential medicines, procurement systems must evolve to reward:

✅ resilience
✅ sustainability
✅ geographic diversification

…not just price alone.

A critical conversation for everyone working to strengthen healthcare systems and ensure reliable, uninterrupted access for patients.

27/03/2026

A strong follow‑up from Chief Transformation & Growth Officer Simon Goeller on the strategic importance of Europe’s last fully integrated penicillin production site in Kundl, Austria.

In his second interview on this topic, he reinforces why preserving this end‑to‑end manufacturing capability is vital for Europe’s security of supply and long‑term resilience - capacity that cannot be quickly rebuilt once lost.

25/03/2026

Antibiotics are critical infrastructure. Modern medicine depends on them. Surgeries, infection treatment, intensive care and routine procedures all rely on effective antibiotics. Without them, life expectancy would decline significantly and healthcare systems would face severe disruption.

Antibiotics are not just healthcare commodities. They are foundational to societal stability and defense readiness alike. If we define energy grids, transport systems and digital networks as critical infrastructure, we must apply the same logic to essential medicines.

In his interview, our Chief Transformation & Growth Officer Simon Goeller explains why antibiotics must be treated as system-relevant infrastructure - not only as part of healthcare policy, but as part of resilience planning.

22/12/2025

As we come to the end of 2025, we’re recapping key milestones that shaped the year for Sandoz. ✨

🔬 We scaled our R&D and manufacturing by acquiring Just-Evotec Biologics' development and manufacturing facilities in Toulouse, and breaking ground on expanded biosimilars manufacturing capacity in Slovenia.

📢 We also brought key conversations to the global stage, hosting the first ‘Talking Biosimilars’ event at the World Health Summit, bringing leaders together to explore how we can accelerate access to biosimilar medicines.

💙 Our commitment to patients and the planet remained strong. We continued championing the community and advanced our decarbonization journey with a 10-year Power Purchase Agreement with Elawan Energy, enabling us to meet almost 90% of our current electricity demand in Europe with new-build solar power.

Our people and culture were central to our success, together we:

👉 Launched OurShare, a global all-employee share program
👉 Engaged future healthcare leaders at One Young World – Munich 2025
👉 Were recognized by Stonewall as a Top Global Employer for LGBTQI+ inclusion 🏳️‍🌈 🏳️‍⚧️️‍🌈

Looking ahead to 2026, we will be celebrating three anniversaries that define who we are: 140 years of heritage, 80 years of antibiotics and 20 years of biosimilars.

Wishing everyone happy holidays and a wonderful New Year!

05/12/2025

Patient advocates are calling for concrete actions to make quality medicines accessible for everyone.

In the consensus statement, they’ve outlined six key actions to turn this vision into a reality, including:
🔹 Creating education programs
🔹 Streamlining approval processes
🔹 Having multi-stakeholder collaboration.

📽️ Hear from patient advocates from the Making Access Happen community on the importance of education and collaboration to drive access.

Learn more in the consensus statement:https://sandoz-com.cms.sandoz.com/sites/default/files/Media%20Documents/Making%20Access%20Happen%20Consensus%20Statement%202025.pdf

03/12/2025

Today is International Day of Persons with Disabilities, a moment to reaffirm our commitment to disability inclusion at Sandoz.

With more than 1 billion people worldwide living with permanent, temporary, visible, or invisible disabilities, our focus goes beyond awareness.

We recognize that inclusion starts with empathy, shared language, and practical steps and when accessibility is prioritized, engagement and performance rise across our teams.

From integrating disability awareness into onboarding and leadership programs, to conducting accessibility audits and standardizing inclusive hiring practices. There are just some of the ways that we’re making inclusion part of how we work, lead, and connect every day, championed by our Communities of Belonging. 💙

03/10/2025

Biosimilars are essential for making life-saving medicines more affordable and accessible. In this video, patient advocates from the Making Access Happen community share how biosimilar adoption can support health equity and sustainable healthcare.

Key strategies include educating patients and healthcare professionals, leveraging digital technologies, and harmonizing standards. With supportive policies and global collaboration, biosimilars can drive lasting change.

Learn more and join the community: https://www.sandoz.com/makingaccesshappen/

17/09/2025

When patient advocates understand how pharmaceutical patents work, they can engage more strategically in access advocacy. But patent systems feel overwhelming to many organizations.

Digestive Cancers Europe - for Patients is hosting a patent education webinar for patient organizations on 6 November. You'll learn how patents can influence the availability of medicines, sometimes delaying or limiting timely access for patients.

Learn from our Global Head of IP alongside advocates who've built successful campaigns using patent knowledge.

Thursday 6 November | 4:00-5:30 PM CET | Register now: https://events.zoom.us/ev/ApxG1qgYa92cexuXPYw5aMWa6mGt-P8w6LWCo5KWvXTIIRPVEgvb~AszpLAc1iZA09e-owdIRUy-yxXcnRPu2yXJnZC0HlPIgk2KSUhOs4hwFwg

Access challenges have many layers, and patents are one area where advocates often want a better understanding. But where do you even start with such a complex system?

On 6 November, we're hosting a patent education webinar for patient advocates. You’ll learn how patents can influence the availability of medicines, sometimes delaying or limiting timely access.

The session will cover the essentials of navigating these barriers, with insights from an industry expert and advocates who have successfully applied patent knowledge in their access work.

From the basics to real-world applications, this webinar will give patient organisations the foundation they need to join patent discussions with confidence.

🗓Thursday 6 November ⏰4:00-5:30 PM CET

Register now👉 https://events.zoom.us/ev/ApxG1qgYa92cexuXPYw5aMWa6mGt-P8w6LWCo5KWvXTIIRPVEgvb~AszpLAc1iZA09e-owdIRUy-yxXcnRPu2yXJnZC0HlPIgk2KSUhOs4hwFwg

Sandoz Global EU Can Beat Cancer EU Science & Innovation EU Science Hub - Joint Research Centre Generation Patient Arthritis Consumer Experts fans

01/09/2025

At Sandoz, we are committed to ensuring our colleagues have what they need to continue their personal and professional growth journeys.

From coaching and mentoring to leadership programs to new stretch opportunities, our people are supported every step of the way. ✨

Thank you, Praveen, for sharing your experience!

Whatever your goal, start your career conversation with Sandoz. Visit Sandoz.com/careers

14/08/2025

We have been recognized by Stonewall as a Top Global Employer for LGBTQI+ inclusion! 🏳️‍🌈 🏳️‍⚧️

Our submission earned Silver in the Global Workplace Equality Index, Stonewall’s benchmarking and assessment tool designed to support global workplaces to create inclusive environments. This reflects the inclusive culture we are building at Sandoz – one where everyone feels heard, safe, respected and empowered to be themselves.

What stood out for Stonewall was:
🌍 The strength of our Pride Communities of Belonging around the world
🍎 Our reverse mentoring program
💼 Our gender-neutral workplace standards
📖 The publication of our Trans Identity Guide

These efforts help create a workplace where inclusion is not just a value, but a lived experience. Thank you to everyone who made this recognition possible. Next time, we’ll be pushing for Gold! 🌟